Drug Profile
Research programme: ophthalmology therapeutics - Lee's Pharmaceutical
Alternative Names: ZK-009Latest Information Update: 29 Aug 2023
Price :
$50
*
At a glance
- Originator Lee's Pharmaceutical; Unknown
- Developer Lee's Pharmaceutical
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Eye disorders
Most Recent Events
- 29 Aug 2023 Discontinued - Preclinical for Eye disorders in China (Ophthalmic)
- 28 Nov 2019 No recent reports of development identified for preclinical development in Eye-disorders in China (Ophthalmic)